The pharmaceutical industry is operating in a more litigious and aggressive environment than ever before. Are the ‘big bad pharma companies’ all to blame? Or should the guilty finger be pointed at the vicious claimant ‘shark lawyers’? Either way, there are vexing issues facing the pharma industry which need tackling.
With drug safety issues being thrust into the limelight, and recalls of dangerous or faulty products dramatically increasing, it is now as crucial as ever to dominate these concerns and implement strategic risk management systems. Protecting corporate reputation and brand image when matters take a turn for the worst is also fundamental when the stakes are so high.
The debate on funding continues, with many claimants finding themselves astray in no-man’s land. Experts strive to find practical solutions to the troublesome issue of guarantying access to justice.
Clinical trials too have caused quite a stir, with questions being raised as to what extent –if at all- the Regulator is liable when things go terribly wrong.
Of utmost importance, the need to be informed of the latest US trends and of what is going on in continental Europe. This event has been specifically designed to provide you with a comprehensive and intensive review of the very latest developments in product liability law and the important business considerations that must underlie product liability strategies.